OGN

Organon Stock Analysis

AI Rating

Fair
  • Quality9/10
  • Growth 0/10
  • Momentum 3/10
Organon sales and earnings growth
OGN Growth
Low
  • Revenue Y/Y -1.69%
  • EPS Y/Y -61.93%
  • FCF Y/Y 4.14%
Organon gross and profit margin trends
OGN Profitability
Neutral
  • Gross margin 55.00%
  • EPS margin 8.00%
  • ROIC 9.50%
Organon recent dividend growth
OGN Dividends
  • Dividend yield 1.01%
  • Growth 3Y -26.81%
  • Payout ratio 31%
Organon net debt vs free cash flow
OGN Risk
Poor
  • Debt / Equity 9.7
  • Debt / FCF 10.5
  • Interest coverage 2.4

Organon stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Drug Manufacturers - General stocks ↗